Supreme Court Rules on Gene Patents

The Supreme Court’s decision to invalidate patents on human genes changes the landscape of Personalized Medicine, making it possible for more patients to benefit from genetic testing while substantially lowering the cost of that testing.

“PGXL’s mission is to advance Personalized Medicine for the improvement of people’s lives,” says Dr. Roland Valdes, Jr., President of PGXL Laboratories. “This opens the door for PGXL Laboratories and others to provide a greater diversity of tests in the very near future.”

The case is Association for Molecular Pathology v. Myriad Genetics, 12-398.


by Content_Management
This entry was posted in Footnote. Bookmark the permalink.

Comments are closed.